Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPRTUNTI: Uterus Transplantation for Uterine Factor Infertility
NCT05646992Phase 3Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Mar 2023
- Primary completion
- Feb 2033
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial in uterine factor infertility (UFI), sponsored by Johns Hopkins University. Primary endpoint: Successful delivery of viable baby at 5 years. Started Mar 2023; status: recruiting.
02
Conditions
uterine factor infertility (UFI)
Beyond the preview
Go deeper on NCT05646992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05646992.